This evaluation will allow assessing the status of the implementation of the Drugs Strategy 2013-2020, as well as of the Action Plan 2013-2016 in terms of both outputs and impact of these outputs. It will look at the effectiveness, efficiency, relevance and coherence of the actions undertaken on basis of the Action Plan, as well as at the achieved EU added-value. The evaluation will contribute to ensuring that the objectives of the EU Drugs Strategy are achieved by 2020, by highlighting the areas where progress has been achieved and those where efforts have not yet been sufficient. The outcome of the evaluation will also contribute to the decision whether the Commission will propose a new Action Plan to cover the period 2017-2020.
The roadmap informs stakeholders and citizens about the initiative.
Stakeholders are invited to provide feedback on the roadmaps within 4 weeks after they are published.
Feedback can be provided in all official languages of the EU, may be published and taken into account by the Commission services during the evaluation process.
You can view the feedback received on this proposal.
Disclaimer: The information and views contained in the feedbacks published are those of the authors and do not reflect the official opinion of the European Commission. The Commission does not guarantee the accuracy of the information contained therein. Neither the Commission nor any person acting on the Commission's behalf may be held responsible for the content and the use which may be made of the information contained therein.
The consultation strategy outlines the consultation objectives, maps the relevant stakeholders and explains which consultation methods and tools the European Commission is considering using in the course of the evaluation. Please note that this document is provided for information only and does not commit the European Commission in any way.
The open public consultation linked to this initiative closed on 31/05/2016. Please visit the open public consultation webpage for more information.